Hyperglycemia
Conditions
Interventions
Sponsors
Affiliated Hospital of Guizhou Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. In the screening period, the subjects are not limited to gender, aged between 18 and 80 years. 2. The patients who had been diagnosed with diabetes mellitus had higher blood glucose, which met who 1999 diabetes diagnostic criteria. 3. Patients who were treated with prednisone acetate >= 5mg / D or methylprednisolone >= 4mg / D at the time of enrollment had been treated for more than 1 month and would continue to use for more than 16 weeks. 4. Subjects with blood glucose >= 12 mmol / L at least twice within 24 hours were randomly selected. 5. Subjects with BMI >= 20.0kg/m2. 6. Subjects who can and are willing to provide written informed consent and comply with the requirements of this study.
Exclusion criteria
Exclusion criteria: 1. Pregnant women or women planning to get pregnant during the study period, women in lactation period or women with fertility without effective and medically approved contraceptive methods. 2. Patients with type 1 diabetes or diabetic ketoacidosis. 3. Patients with a history of medullary thyroid carcinoma or family history and type 2 multiple endocrine neoplasia syndrome. 4. Patients with congestive heart failure classified as grade IV by the New York Heart Association (NYHA). 5. Patients with inflammatory bowel disease and diabetic gastroparesis. 6. 73 M2 (Cockcroft Gault formula). 7. Patients with severe liver damage. 8. Patients participating in other clinical trials; 9. Subjects considered unsuitable for clinical trials for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| c-peptide;pancreatic glucagon;interleukin-6;Hypersensitive C-reactive protein;body composition; | — |
Countries
China
Contacts
Public ContactZhang Miao
Affiliated Hospital of Guizhou Medical University
Outcome results
None listed